Braintale

BrainTale is a medtech specialist in white matter, a long-underestimated area of interest in neurosciences. The company offers a platform of unique clinically-validated digital biomarkers, which are employed in daily practice as well as in drug developments. Biomarkers are derived from magnetic resonance imaging, non-invasive measurements providing sensitive and reliable assessments of white matter alterations. Braintale establishes a new standard for measuring the brain that is both relevant and useful for patients, doctors, researchers, and drug developers. 

Supporting clinical decision-making, these data are decisive for neurology and intensive care management using clinically validated predictive solutions. BrainTale allows the identification of patients at risk, early diagnosis, follow-up of disease progression and effectiveness of treatments in neurology, in particular for demyelinating diseases (such as multiple sclerosis), neurodegenerative diseases (such as Alzheimer's disease or Parkinson's disease) or trauma brain injury.